CorMedix's earnings of $0.05 exceeded expectations, and profits were also higher than anticipated.

CorMedix (NASDAQ: CRMD) reported a first-quarter earnings per share of $0.220, exceeding analysts' expectations of $0.170 by $0.05. The reported profit for this quarter was set at $31.2 million, slightly higher than the anticipated $31 million.

CorMedix shares closed at $10.77, reflecting a 31.18% increase over the past three months and a remarkable 162.04% gain over the last year. In the last 90 days, CorMedix saw three positive earnings per share results compared to one negative. Discover how CorMedix’s stock price reacted to previous earnings reports. According to InvestingPro, CorMedix's financial health score is rated as "Quite Good." Explore the latest earnings reports and all financial details of CorMedix here. Stay updated on balance sheet developments by visiting the Investing.com Earnings Calendar.